TIDMAXI
RNS Number : 4982E
Axiom European Financial Debt Fd Ld
08 May 2017
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, TO U.S PERSONS OR IN OR INTO THE
UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
This announcement is an advertisement and not a prospectus. Any
investment in any shares referred to in this announcement may be
made only on the basis of information in the prospectus (the
"Prospectus") published today by Axiom European Financial Debt Fund
Limited.
8 May 2017
Axiom European Financial Debt Fund Limited
Placing Programme
Axiom European Financial Debt Fund Limited ("Axiom" or the
"Company") today announces that it has published a prospectus
approved by the UK Listing Authority relating to the creation of a
placing programme (the "Placing Programme") pursuant to which the
Company will be able to issue up to 500 million new ordinary shares
of no par value ("Shares").
The Placing Programme will enable the Company to raise capital
in an efficient and cost-effective manner over the next 12 months.
The Placing Programme Price will include at the time of allotment a
premium to the Net Asset Value per Share intended, inter alia, to
cover the costs and expenses of the relevant placing of Shares
(including, without limitation, any placing commissions).
The Prospectus will shortly be available on the national storage
mechanism at www.morningstar.co.uk/uk/NSM and will also be
available on the Company's website at http://www.axiom-ai.com/.
Capitalised terms used in this announcement shall have the same
meanings as defined in the Prospectus unless otherwise defined
herein.
Highlights:
-- The Placing Programme is intended to enable the Company to
raise additional capital through the issue of up to 500 million
Shares in the period from 8 May 2017 to 7 May 2018 (or, if sooner,
the date on which the Placing Programme is fully utilised).
-- Funds raised from the Placing Programme will be used for
investment in Financial Institution Investment Instruments in
accordance with the Company's investment policy and are expected
(but without restricting the Company) in particular to be deployed
in the liquid relative value and less liquid relative value
strategies.
-- Liberum Capital Limited ("Liberum") has been appointed as
Sole Financial Adviser and Bookrunner in relation to the Placing
Programme.
-- All Shares issued pursuant to the Placing Programme will,
when issued and fully paid, confer the right to receive all
dividends or other distributions made, paid or declared, if any, by
reference to a record date after the date of their issue.
The information communicated in this announcement is inside
information for the purposes of Article 7 of Market Abuse
Regulation 596/2014 ("MAR"). For the purposes of MAR and Article 2
of Commission Implementing Regulation (EU) 2016/1055, this
announcement is being made on behalf of the Company by Steve Mann
of Elysium Fund Management Limited.
For further information please contact:
Axiom Alternative Investments
SARL
David Benamou, Managing
Partner
Jerome Legras, Managing
Partner
Tel: + 44 (0)20 3807
0670
Liberum Capital Limited (Sole Financial Adviser
and Bookrunner)
Richard Bootle / Henry Freeman / Jonathan Wilkes-Green
Tel: +44 (0)20 3100 2222
PLACING PROGRAMME STATISTICS
Maximum number of Shares under 500 million Shares
the Placing Programme
Placing Programme Price Not less than the
prevailing Net
Asset Value (cum
income) per Share
at the time of
issue plus a premium
to cover the costs
and expenses of
the relevant placing
of Shares (including,
without limitation,
any placing commissions).
ISIN for Ordinary Shares GG00BTC2K735
SEDOL for Ordinary Shares BTC2K73
EPIC/TIDM AXI
This announcement is not for distribution, directly or
indirectly, in or into the United States of America (including its
territories and possessions, any state of the United States of
America and the District of Columbia) (the "United States"),
Australia, Canada, Japan or South Africa. This announcement does
not constitute, or form part of, an offer to sell, or a
solicitation of an offer to purchase, any securities in the United
States, Australia, Canada, Japan or South Africa. The securities of
the Company have not been and will not be registered under the U.S.
Securities Act of 1933, as amended (the "Securities Act") or the US
Investment Company Act of 1940, as amended and may not be offered
or sold directly or indirectly in or into the United States or to
or for the account or benefit of any U.S. Person (within the
meaning of Regulation S under the Securities Act). The securities
referred to herein have not been registered under the applicable
securities laws of Australia, Canada, Japan or South Africa and,
subject to certain exceptions, may not be offered or sold within
Australia, Canada, Japan or South Africa or to any national,
resident or citizen of Australia, Canada, Japan or South
Africa.
This announcement has been issued by and is the sole
responsibility of the Company.
No representation or warranty, express or implied, is or will be
made as to, or in relation to, and no responsibility or liability
is or will be accepted by, Liberum Capital Limited ("Liberum") or
by any of its affiliates or agents as to or in relation to the
accuracy or completeness of this announcement or any other written
or oral information made available to or publicly available to any
interested party or its advisers and any liability therefore is
expressly disclaimed.
Liberum, which is authorised and regulated in the United Kingdom
by the Financial Conduct Authority, is acting as financial adviser
to the Company and is acting for no-one else in connection with the
Placing Programme and the contents of this announcement and will
not be responsible to anyone other than the Company for providing
the protections afforded to clients of Liberum or for providing
advice in connection with the Placing Programme and the contents of
this announcement or any other matter referred to herein.
This announcement includes statements that are, or may be deemed
to be, "forward-looking statements". These forward-looking
statements can be identified by the use of forward-looking
terminology, including the terms "believes", "estimates",
"anticipates", "expects", "intends", "may", "will" or "should" or,
in each case, their negative or other variations or comparable
terminology. These forward-looking statements include all matters
that are not historical facts. All forward-looking statements
address matters that involve risks and uncertainties. Accordingly,
there are or will be important factors that could cause the
Company's actual results to differ materially from those indicated
in these statements. Any forward-looking statements in this
announcement reflect the Directors' current views with respect to
future events and are subject to these and other risks,
uncertainties and assumptions relating to the Company's operations,
results of operations and growth strategy. Prospective investors
should specifically consider the factors identified in this
announcement and the Prospectus which could cause actual results to
differ before making an investment decision. These forward looking
statements speak only as of the date of this announcement. Subject
to its legal and regulatory requirements, the Company expressly
disclaims any obligation to update or revise any forward-looking
statement contained herein to reflect changes in expectations with
regard thereto or any change in events, conditions or circumstances
on which any statement is based, unless required to do so by law or
any appropriate regulatory authority, including FSMA, the London
Stock Exchange, the GFSC, the RCIS Rules, the Prospectus Rules, MAR
and the Disclosure Guidance and Transparency Rules.
This announcement does not constitute an invitation to engage
investment activity.
The value of investments may go down as well as up, and all of
an investment in the Company would be at risk. Past performance is
not a guide to future performance and the information in this
announcement or any documents relating to the Placing Programme
cannot be relied on as a guide to future performance. Persons
needing advice should contact a professional adviser.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBXGDUISGBGRI
(END) Dow Jones Newswires
May 08, 2017 10:00 ET (14:00 GMT)
Axiom European Financial... (LSE:AXI)
Historical Stock Chart
From Apr 2024 to May 2024
Axiom European Financial... (LSE:AXI)
Historical Stock Chart
From May 2023 to May 2024